...
首页> 外文期刊>Obstetrical and gynecological survey >Labour Induction With Prostaglandins: A Systematic Review and Network Meta-Analysis
【24h】

Labour Induction With Prostaglandins: A Systematic Review and Network Meta-Analysis

机译:前列腺素引产:系统评价和网络Meta分析

获取原文
获取原文并翻译 | 示例

摘要

Prostaglandins are a widely used method of labor induction. Individual studies have compared different prostaglandins, dosages, and routes of treatment, but there have not been single studies that have compared them all simultaneously. The current study uses network meta-analysis to compare multiple prostaglandins as well as dosages and route of treatment to estimate which treatment is best for a range of obstetric outcomes. A search of the Cochrane Pregnancy and Childbirth Group's Database of Trials was used to find eligible trials. To be eligible, trials had to be randomized clinical trials comparing a prostaglandin or prostaglandin analog versus a placebo or different prostaglandin, or comparing 2 different forms or doses of 1 prostaglandin, specifically examining the impact on labor induction or cervical ripening in the third trimester. Only trials exclusively studying women with a viable fetus were included. The 12 types of prostaglandin or prostaglandin analog included were intracervical prostaglandin E-2; vaginal misoprostol tablet or sustained-release pessary; oral misoprostol tablet; vaginal prostaglandin E-2 as tablets, gel, pessary, or sustained-release pessary; prostaglandin F-2a gel; and oral misoprostol solution. Outcomes included serious maternal morbidity or death, serious neonatal morbidity or perinatal death, vaginal delivery not achieved within 24 hours, uterine hyperstimulation with fetal heart rate changes, and cesarean delivery.
机译:前列腺素是广泛使用的引产方法。个别研究比较了不同的前列腺素,剂量和治疗途径,但尚无单一研究同时比较它们。当前的研究使用网络荟萃分析来比较多种前列腺素以及治疗的剂量和途径,以评估哪种治疗最适合一系列产科预后。使用Cochrane妊娠和分娩组的试验数据库进行搜索,以找到符合条件的试验。为了符合条件,试验必须是随机临床试验,将前列腺素或前列腺素类似物与安慰剂或不同的前列腺素进行比较,或比较2种不同形式或剂量的1种前列腺素,特别是检查对妊娠中期分娩或宫颈成熟的影响。仅包括专门研究具有存活胎儿的妇女的试验。所包括的12种前列腺素或前列腺素类似物是脑内前列腺素E-2。阴道米索前列醇片或缓释子宫托;口服米索前列醇片;阴道前列腺素E-2,呈片剂,凝胶剂,子宫托或持续释放子宫托;前列腺素F-2a凝胶;和口服米索前列醇溶液。结果包括严重的母亲发病或死亡,严重的新生儿发病或围产期死亡,24小时内未达到阴道分娩,子宫过度刺激以及胎儿心率改变和剖宫产。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号